Experimental drug aims to help critically ill pneumonia patients breathe easier
Disease control
Completed
This study tested whether adding the experimental drug AON-D21 to standard pneumonia treatment helps patients with severe pneumonia who need intensive care. Researchers compared AON-D21 against a placebo in 150 hospitalized patients to see if it was safe and helped patients recov…
Phase: PHASE2 • Sponsor: Aptarion Biotech AG • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC